Home/Filings/4/0001140361-16-080556
4//SEC Filing

Tobira Therapeutics, Inc. 4

Accession 0001140361-16-080556

CIK 0001311596operating

Filed

Sep 21, 8:00 PM ET

Accepted

Sep 22, 4:45 PM ET

Size

21.8 KB

Accession

0001140361-16-080556

Insider Transaction Report

Form 4
Period: 2016-09-20
Transactions
  • Purchase

    Common Stock, par value $0.001 per share

    2016-09-20$39.03/sh+1,070,000$41,762,1002,979,000 total(indirect: By managed account)
  • Purchase

    Common Stock, par value $0.001 per share

    2016-09-20$39.23/sh+1,000$39,2302,980,000 total(indirect: By managed account)
  • Purchase

    Common Stock, par value $0.001 per share

    2016-09-20$38.87/sh+220,000$8,551,4003,200,000 total(indirect: By managed account)
  • Purchase

    Common Stock, par value $0.001 per share

    2016-09-20$39.07/sh+5,000$195,3503,205,000 total(indirect: By Matthew Halbower)
  • Purchase

    Common Stock, par value $0.001 per share

    2016-09-21$39.12/sh+3,200$125,1843,208,200 total(indirect: By David Pickering)
  • Purchase

    Common Stock, par value $0.001 per share

    2016-09-21$38.97/sh+31,000$1,208,0703,239,200 total(indirect: By managed account)
  • Purchase

    Common Stock, par value $0.001 per share

    2016-09-21$39.14/sh+195,000$7,632,3003,434,200 total(indirect: By Matthew Halbower)
  • Purchase

    Common Stock, par value $0.001 per share

    2016-09-22$39.26/sh+1,209$47,4653,435,409 total(indirect: By managed account)
  • Purchase

    Common Stock, par value $0.001 per share

    2016-09-22$39.40/sh+27,791$1,094,9653,513,200 total(indirect: By managed account)
  • Purchase

    Common Stock, par value $0.001 per share

    2016-09-22$39.30/sh+50,000$1,965,0003,485,409 total(indirect: By managed account)
  • Purchase

    Common Stock, par value $0.001 per share

    2016-09-22$39.45/sh+20,000$789,0003,533,200 total(indirect: By managed account)
Footnotes (1)
  • [F1]The reporting person is the investment manager for PWCM Master Fund Ltd, an exempted company formed in the Cayman Islands, Pentwater Equity Opportunities Master Fund, Ltd., an exempted company formed in the Cayman Islands, Oceana Master Fund, Ltd., an exempted company formed in the Cayman Islands, Amundi Absolute Return Pentwater Fund Plc, a private fund formed in Ireland, Pentwater Event Driven Cayman Fund Limited, an exempted company formed in the Cayman Islands, Pentwater Merger Arbitrage Master Fund LTD, an exempted company formed in the Cayman Islands, and LMA SPC for and on behalf of MAP 98 Segregated Portfolio, a segregated portfolio company formed in the Cayman Islands, which directly own the shares.

Documents

1 file

Issuer

Tobira Therapeutics, Inc.

CIK 0001311596

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001311596

Filing Metadata

Form type
4
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 4:45 PM ET
Size
21.8 KB